EliasHSarkisMD

Psychiatry • Gainesville, FL

Child & Adolescent Psychiatry

Owner at Sarkis Clinical Trials

Join to view full profile

Dr. Sarkis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sarkis' full profile

Already have an account?

Office
529 Nw 60th St
Gainesville, FL 32607
Phone+1 352-331-5100
Is this information wrong?

Education & Training

University of FloridaFellowship, Child and Adolescent Psychiatry, 1989 - 1991
University of FloridaResidency, Psychiatry, 1986 - 1989
Faculté de MédecineClass of 1985, MD, Cum Laude

Certifications & Licensure

FL State Medical License 1987 - 2026
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Awards, Honors, & Recognition

Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Pediatric Schizophrenia Efficacy and Safety Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30
Completed
Phase 3
Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01
Completed
Phase 3
PRC-063 in Adolescent ADHD Start of enrollment: 2014 Apr 01
Completed
Phase 3
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD Start of enrollment: 2014 May 01
Completed
Phase 3
Dasotraline Pediatric ADHD Study Start of enrollment: 2015 Apr 01
Completed
Phase 2, Phase 3
Dasotraline Pediatric Extension Study Start of enrollment: 2015 Jun 30
Completed
Phase 3
Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Start of enrollment: 2015 Jun 18
Completed
Phase 3
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder Start of enrollment: 2015 Jul 27
Completed
Phase 3
A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting Start of enrollment: 2015 Aug 01
Completed
Phase 3
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) Start of enrollment: 2015 Nov 19
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study.
Subramanian, S., Schnell, G., Iulio, J., Gupta, A., Shapiro, A., Lopuski, A., Peppercorn, A., Aldinger, M., Hebner, C., Cathcart, A., Sarkis, E.> ;Future Virology. 2023 Nov 1
Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19.
Sacha Satram, Parima Ghafoori, Carolina M Reyes, Tom J H Keeley, Helen J Birch, Dimitra Brintziki, Melissa Aldinger, Elizabeth Alexander, Amanda Lopuski, Elias H Sarki...> ;Journal of Patient-Reported Outcomes. 2023 Sep 13
2 citations
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial.
Adrienne E Shapiro, Elias Sarkis, Jude Acloque, Almena Free, Yaneicy Gonzalez-Rojas, Rubaba Hussain, Erick Juarez, Jaynier Moya, Naval Parikh, David Inman, Deborah Ceb...> ;Open Forum Infectious Diseases. 2023 Aug 1
160 citations
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Anil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, Manuel Crespo Casal, Jaynier Moya, Diego Rodrigues Falci, Elias Sarkis, Joel Solis, Hanzhe Zheng, Nicola Scott, Andre...> ;JAMA. 2022 Apr 5
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adult...
Stephen V. Faraone, Ann C. Childress, Steve Caras, Valerie Arnold, C. Brendan Montano, Elias H. Sarkis, Joel L. Young> ;The Journal of Clinical Psychiatry. 2021 Aug 24
2 citations
Post hoc Responder and Remission Analyses from Two Studies of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults with Attention-Deficit/Hyperactivity Disorder.
Lenard A. Adler, Brigitte Robertson, Jie Chen, Elias Sarkis> ;Journal of Child and Adolescent Psychopharmacology. 2020 Aug 28
A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults.
Cynthia Richards, Dan V. Iosifescu, Rajnish Mago, Elias Sarkis, Brooke Geibel, Matthew Dauphin, Roger S. McIntyre, Richard H. Weisler, Olga Brawman-Mintzer, Joan Gu, M...> ;Journal of Clinical Psychopharmacology. 2018 Aug 1
10 citations
A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders.
Robert L. Findling, Adelaide S. Robb, Melissa P. DelBello, Michael Huss, Nora K. McNamara, Elias H. Sarkis, Russell E. Scheffer, Lis H. Poulsen, Grace Chen, Ole Lemmin...> ;Journal of Child and Adolescent Psychopharmacology. 2017 Oct 16
8 citations
A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate ...
Cynthia Richards, Dan V. Iosifescu, Rajnish Mago, Elias Sarkis, James M. Reynolds, Brooke Geibel, Matthew Dauphin> ;Journal of Psychopharmacology. 2017 Aug 31
10 citations
Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients.
Robert L. Findling, Adelaide S. Robb, Melissa P. DelBello, Michael Huss, Nora K. McNamara, Elias H. Sarkis, Russell E. Scheffer, Lis H. Poulsen, Grace Chen, Ole Lemmin...> ;Journal of Child and Adolescent Psychopharmacology. 2017 Aug 1
4 citations
Atomoxetine Increased Effect over Time in Adults with Attention-Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double-Blind, Placebo...
Linda Wietecha, David B. Clemow, Andrew S. Buchanan, Joel L. Young, Elias H. Sarkis, Robert L. Findling> ;CNS Neuroscience & Therapeutics. 2016 Jul 1
1 citations
Atomoxetine monotherapy compared with combination therapy for the treatment of ADHD: a retrospective chart review study
David B. Clemow, Oren W Mason, Elias H Sarkis, Dustin D. Ruff, Brad D Berman, Craig L. Donnelly, Adelaide S. Robb, Donna S Holland, Kory Schuh, Janet M Barnes, Andre B...> ;Expert Review of Neurotherapeutics. 2015 Oct 21
13 citations
Addressing Attention-Deficit/Hyperactivity Disorder in the Workplace
Elias Sarkis> ;Postgraduate Medicine. 2014 Sep 1
45 citations
Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlle...
Todd M. Durell, Lenard A. Adler, Dave W. Williams, Ahmed Deldar, James J. McGough, Paul E.A. Glaser, Richard L. Rubin, Teresa A. Pigott, Elias Sarkis, Bethany K. Fox> ;Journal of Clinical Psychopharmacology. 2013 Feb 1
48 citations
Once-daily treatment with atomoxetine in adults with attention-deficit/hyperactivity disorder: a 24-week, randomized, double-blind, placebo-controlled trial.
Joel L. Young, Elias Sarkis, Meihua Qiao, Linda Wietecha> ;Clinical Neuropharmacology. 2011 Mar 1
18 citations
Executive function deficits in children with attention-deficit/ hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study
Atilla Turgay, Lawrence D. Ginsberg, Elias H. Sarkis, Rakesh K. Jain, Ben Adeyi, Joseph Gao, Bryan Dirks, Thomas Babcock, Brian Scheckner, Cynthia Richards, Robert Las...> ;Journal of Child and Adolescent Psychopharmacology. 2010 Dec 27
87 citations
Atomoxetine Alone or Combined With Fluoxetine for Treating ADHD With Comorbid Depressive or Anxiety Symptoms
Christopher J. Kratochvil, Jeffrey H. Newcorn, L. Eugene Arnold, David A. Duesenberg, Graham J. Emslie, Humberto Quintana, Elias H. Sarkis, Karen Dineen Wagner, Haitao...> ;Journal of the American Academy of Child and Adolescent Psychiatry. 2005 Sep 1
19 citations
Self-Regulation and Inhibition in Comorbid ADHD Children: An Evaluation of Executive Functions:
Stephanie Moulton Sarkis, Elias H. Sarkis, David Marshall, James Archer> ;Journal of Attention Disorders. 2005 Feb 1
1 citations
Compliance with FDA recommendations for pemoline.
Elias H. Sarkis> ;Journal of the American Academy of Child and Adolescent Psychiatry. 2003 Apr 1
22 citations
GW320659 for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children
Joseph DeVeaugh-Geiss, C. Keith Conners, Elias H. Sarkis, Paul Winner, Lawrence D. Ginsberg, J. Michael Hemphill, Antonio Laurenza, Cathleen F. Barrows, Christopher J....> ;Journal of the American Academy of Child and Adolescent Psychiatry. 2002 Aug 1
5 citations
Fluoxetine and anorexia.
Brad Lyles, Elias H. Sarkis, John P. Kemph> ;Journal of the American Academy of Child and Adolescent Psychiatry. 1990 Nov 1
"Model" behavior.
Sarkis, E. H.> ;Science. 2000 Mar 24
Persistent sinus nodal electrograms during abnormally prolonged postpacing atrial pauses in sick sinus syndrome in humans: sinoatrial block vs overdrive suppression.
Asseman, P., Berzin, B., Desry, D., Vilarem, D., Durand, P., Delmotte, C., Sarkis, E. H., Lekieffre, J., Thery, C.> ;Circulation. 1983 Jul
Sinus region electrograms.
Asseman, P., Berzin, B., Desry, D., Vilarem, D., Durand, P., Sarkis, E. H., Thery, C., Lekieffre, J.> ;Circulation. 1983 May
Orthostatic hypotension due to prolactin-secreting pituitary adenoma.
Ducloux, G., Manouvrier, J., Wemeau, J. L., Christiaens, J. L., Barbry, M., Sarkis, E. H.> ;Am Heart J. 1984 Jan
Join now to see all

Press Mentions

How to Support Employees Living with ADHDMarch 11th, 2021
How a Physician Treats ADHD with Combination TherapyAugust 6th, 2019

EliasHSarkisMD

Dr. Sarkis is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.